Diferencia entre revisiones de «Template:CMV neurologic disease treatment»

Sin resumen de edición
(Strip translate tags to enable SMW subobject creation)
 
(No se muestran 4 ediciones intermedias de 2 usuarios)
Línea 1: Línea 1:
*[[Ganciclovir]] 5mg/kg IV q12hrs daily x 21 days FOLLOWED BY 5mg/kg IV q24hrs +
*{{AntibioticDose|disease=CMV neurologic disease|drug=Ganciclovir|dose=5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs|context=Combined with Foscarnet|population=Adult}} +
**[[Foscarnet]] 90mg/kg IV q12hrs x 21 days THEN 90-120mg/kg IV q24hrs
**{{AntibioticDose|disease=CMV neurologic disease|drug=Foscarnet|dose=90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs|context=Combined with Ganciclovir|population=Adult}}

Revisión actual - 02:54 20 mar 2026

  • Ganciclovir 5mg/kg IV q12hrs x 21 days then 5mg/kg IV q24hrs +
    • Foscarnet 90mg/kg IV q12hrs x 21 days then 90-120mg/kg IV q24hrs